V Bio Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Noord hollandCedric van nevelMaarten ligtenbergRudi beyaertAllard kapteinInnovatiefonds noord hollandShobhit dhawanBrabantse ontwikkelings maatschappijChristina takkeDennis riedlFlanders institute of biotechnologyNetherlands cancer instituteBrabant development agencyMinistry of economic affairsFlanders future tech fundJjdc inc

ExeVir Bio Announces Positive Virus Neutralization Data for XVR012 Against Emerging COVID-19 Omicron Variants

ExeVir Bio Announces Positive Virus Neutralization Data for XVR012 Against Emerging COVID-19 Omicron Variants
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Exevir bioTorsten mummenbrauerExevir linkedinDaniel goochVeronique vandevoordeWallonie entreprendreScius communicationsEuropean unionEuropean investment bankVir bioV bio venturesEuropean investment

AstriVax Awarded €3 Million Grant to Advance therapeutic Hepatitis B Vaccine

AstriVax Awarded €3 Million Grant to Advance therapeutic Hepatitis B Vaccine
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Region flamandeAckermans van haarenStefan klotterHanne callewaertKu leuven gemma frisius fundEurope venture fundFlanders innovationV bio venturesFlanders future techfundThuja capitalVenture fundEquity partnersFortis private equityLassen sie

Funding steers Cardiovascular Pipeline towards Clinical Entry

Biopharma Corteria, which announced an oversubscribed €65M ($71M) Series A co-led by investment firms OrbiMed (US) and Jeito Capital (EU), will be  using the funding to advance its cardiovascular pipeline into the clinic. Click to read more.

Philip janiakThierry laugelMarie laure ozouxBiopharma corteriaErez chimovitsAndreas wallnoeferPhilip janiaCorteria pharmaceuticalsJeito capitalManaging partnerKurma partnersFountain healthcare partnersV bio venturesInvivo capitalOmnes capital

Jeito Capital co-leads EUR 65 million (USD 71 M) financing in Corteria Pharmaceuticals, a French biopharmaceutical company developing novel treatments for cardi

Jeito Capital co-leads EUR 65 million (USD 711M) financing in Corteria Pharmaceuticals, a French biopharmaceutical company developing novel treatments for cardiovascular diseases

France generalUnited statesPhilip janiakAssia mouhoutMarie laure ozouxAndreas wallnoeferJeito capitaladdedJeito corteria pharmaceuticals frenchConsilium strategic communicationsBanque de franceCorteria pharmaceuticalsJeito capitalKurma partnersFountain healthcare partnersV bio venturesInvivo capital